Based on UnitedHealth’s recent results and guidance, we project Q1 2025 figures as follows.  In Q1 2024 UNH had $99.8B revenue ([www.sec.gov](https://www.sec.gov/Archives/edgar/data/731766/000073176624000155/unh-20240331.htm#:~:text=Revenues%3A%20%20,91%2C931)), $7.93B operating income ([www.sec.gov](https://www.sec.gov/Archives/edgar/data/731766/000073176624000155/unh-20240331.htm#:~:text=Depreciation%20and%20amortization%20%20,8%2C086)), and net (loss) $1.41B ([www.sec.gov](https://www.sec.gov/Archives/edgar/data/731766/000073176624000155/unh-20240331.htm#:~:text=Net%20%28loss%29%20earnings%20%20,)) (EPS –$1.53 ([www.sec.gov](https://www.sec.gov/Archives/edgar/data/731766/000073176624000155/unh-20240331.htm#:~:text=%24%20%20,)), largely due to one‐time charges).  Full‐year 2025 guidance is ~$450–455B in revenue ([www.sec.gov](https://www.sec.gov/Archives/edgar/data/731766/000073176625000022/a2024q4exhibit991.htm#:~:text=UnitedHealth%20Group%20affirmed%20the%202025,32%20billion%20to%20%2433%20billion)) (≈12–13% growth over 2024), implying Q1 should be on the order of 10–12% above Q1 2024.  Assuming ~$110B revenue, improved operating margins (no unusual charges) and higher D&A (~$1.05B vs $0.997B in Q1’24 ([www.sec.gov](https://www.sec.gov/Archives/edgar/data/731766/000073176624000155/unh-20240331.htm#:~:text=Depreciation%20and%20amortization%20%20,83%2C845))), we estimate ~ $9.0B operating income and ~$10.05B EBITDA.  After ~$0.9B interest and ~25% taxes, net income is ~$5.9B (EPS ≈$6.38 on ~920M shares).  We assume Q1 cash flow normalizes (~$5.0B from operations vs $1.144B in Q1’24 ([www.sec.gov](https://www.sec.gov/Archives/edgar/data/731766/000073176624000155/unh-20240331.htm#:~:text=Cash%20flows%20from%20operating%20activities,456))) and capex ~$0.8B ([www.sec.gov](https://www.sec.gov/Archives/edgar/data/731766/000073176624000155/unh-20240331.htm#:~:text=,%2811%2C020%29)), giving FCF ≈$4.2B.  The table below summarizes our Q1 2025 projections:

| Company             | Year | Quarter | Revenue        | EBITDA         | Operating Income | Net Income     | Free Cash Flow | EPS  |
|---------------------|------|---------|----------------|----------------|------------------|---------------|---------------|------|
| UnitedHealth Group  | 2025 | 1       | 110000000000   | 10050000000    | 9000000000       | 5875000000    | 4200000000    | 6.38 |

**Sources:** UNH historical financials (10-Q and press releases) ([www.sec.gov](https://www.sec.gov/Archives/edgar/data/731766/000073176624000155/unh-20240331.htm#:~:text=Revenues%3A%20%20,91%2C931)) ([www.sec.gov](https://www.sec.gov/Archives/edgar/data/731766/000073176624000155/unh-20240331.htm#:~:text=Depreciation%20and%20amortization%20%20,8%2C086)) ([www.sec.gov](https://www.sec.gov/Archives/edgar/data/731766/000073176624000155/unh-20240331.htm#:~:text=Net%20%28loss%29%20earnings%20%20,)) ([www.sec.gov](https://www.sec.gov/Archives/edgar/data/731766/000073176625000022/a2024q4exhibit991.htm#:~:text=UnitedHealth%20Group%20affirmed%20the%202025,32%20billion%20to%20%2433%20billion)) ([www.sec.gov](https://www.sec.gov/Archives/edgar/data/731766/000073176624000155/unh-20240331.htm#:~:text=Cash%20flows%20from%20operating%20activities,456)) ([www.sec.gov](https://www.sec.gov/Archives/edgar/data/731766/000073176624000155/unh-20240331.htm#:~:text=,%2811%2C020%29)) for base-year values and company-provided 2025 guidance, with analyst‐adjusted projections.